Topotecan continuous infusion: CA-125 responses including patients pretreated with other schedules of topotecan.
Muggia
Franco
F
Kosloff
Rebecca
R
Liebes
Leonard
L
Hochster
Howard
H
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D018394:CA-125 Antigen / Q000097:blood*; D006801:Humans; D007262:Infusions, Intravenous; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy*; D019772:Topotecan / Q000008:administration & dosage*
D000970:Antineoplastic Agents; D018394:CA-125 Antigen; D019772:Topotecan